Loading...
Durable responses in patients with large B-cell lymphoma and 3+prior lines of therapy who either paused or discontinued epcoritamab monotherapy while in complete response
Cheah, C. Phillips, T. Jurczak, W. Kim, T. M. Linton, K. Vose, J. Jiang, J. Y. Atiya, M. Eskelund, C. Kearns, C.
Cheah, C.
Phillips, T.
Jurczak, W.
Kim, T. M.
Linton, K.
Vose, J.
Jiang, J. Y.
Atiya, M.
Eskelund, C.
Kearns, C.
Abstract
Description
Date
2025
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 169.34 KB
Keywords
Type
Article
Citation
Cheah C, Phillips T, Jurczak W, Kim TM, Linton K, Vose J, et al. Durable responses in patients with large B-cell lymphoma and 3+prior lines of therapy who either paused or discontinued epcoritamab monotherapy while in complete response. Blood. 2025 NOV 3;146.